• Publications
  • Influence
Probiotics and immunity
Probiotics are defined as live microorganisms that, when administered in adequate amounts, confer a health benefit on the host, including the gastrointestinal tract. While this beneficial effect wasExpand
  • 422
  • 20
Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment.
PURPOSE Well-conducted cancer clinical trials are essential for improving patient outcomes. Unfortunately, only 3% of new cancer patients participate in clinical trials. Barriers to patient accrualExpand
  • 488
  • 16
Effects of a problem-solving intervention (COPE) on quality of life for patients with advanced cancer on clinical trials and their caregivers: simultaneous care educational intervention (SCEI):
CONTEXT Patients on investigational clinical trials and their caregivers experience poor quality of life (QOL), which declines as the disease progresses. OBJECTIVE To examine the effect of aExpand
  • 72
  • 10
The Immunobiology of Mushrooms
There has been enormous interest in the biologic activity of mushrooms and innumerable claims have been made that mushrooms have beneficial effects on immune function with subsequent implications forExpand
  • 159
  • 7
Individualized patient education and coaching to improve pain control among cancer outpatients.
PURPOSE An estimated 42% of cancer patients suffer from poorly controlled pain, in part because of patient-related barriers to pain control. The objective of this study was to evaluate the effect ofExpand
  • 195
  • 6
Phase II study of fluorouracil and its modulation in advanced colorectal cancer: a Southwest Oncology Group study.
PURPOSE A variety of fluorinated pyrimidine-based regimens for the treatment of disseminated colorectal cancer have been presented in the medical literature. The Southwest Oncology Group designed aExpand
  • 355
  • 5
Simultaneous care: a model approach to the perceived conflict between investigational therapy and palliative care.
Clinical trials of investigational therapy in patients with advanced cancer may not pay sufficient attention to quality of life (QOL) and supportive care issues, resulting in an adverse impact on theExpand
  • 94
  • 4
Simultaneous care: disease treatment and palliative care throughout illness.
  • F. Meyers, J. Linder
  • Medicine
  • Journal of clinical oncology : official journal…
  • 1 April 2003
  • 88
  • 4
Phase I/II study of paclitaxel, carboplatin, and methotrexate in advanced transitional cell carcinoma: a well-tolerated regimen with activity independent of p53 mutation.
OBJECTIVES To evaluate the feasibility and activity of paclitaxel, carboplatin, and methotrexate in advanced transitional cell carcinoma (TCC) of the urothelium and to relate the activity of thisExpand
  • 40
  • 4
Cardiotoxicity of epirubicin and doxorubicin: assessment by endomyocardial biopsy.
Forty-two evaluable endomyocardial biopsies were obtained from 29 patients treated with epirubicin, the 4'-epimer of doxorubicin in cumulative doses ranging from 147 mg/m2 to 888 mg/m2. In this studyExpand
  • 179
  • 3
  • PDF
...
1
2
3
4
5
...